The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions
Open accessAbstract
he Diabetes Control and Complications Trial (DCCT) (1) and its observational follow-up, the Epidemiology of Diabetes Interventions and Complications (EDIC) Study (2), are celebrating the 30th anniversary since the start of the DCCT and 20th since the reporting of the DCCT primary results (3).During the past three decades, our understanding of the relationship between metabolic control and complications and the treatment of type 1 diabetes (T1D) has been transformed by the results of DCCT/EDIC.Most importantly, the long-term prospects for patients have dramatically improved with the adoption of intensive therapy designed to achieve near-normal glycemia as the standard of care of T1D.In this Perspective, we present an overview of the major scientific advances provided by the DCCT/EDIC Research Group, the resulting changes in therapy that have improved long-term outcomes in patients with T1D worldwide, and the challenges that remain.(1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992)(1993) While retinopathy was the primary outcome, nephropathy and neuropathy were important secondary outcomes, as were CVD and quality of life (1).With the recognition that severe hypoglycemia was the most frequent serious From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications DIABETES CONTROL AND COMPLICATIONS TRIAL
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Self-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Self-citationSeaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 1×
“Finally, studies have consistently identified hypoglycemia, a risk inherent in current day INT, as a major barrier to implementation of INT (79).”
BackgroundThe Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Long-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602
Diabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555 · cited 2×
“96% of the statistical difference between the treatment groups in risk of retinopathy onset or progression and 98 and 92% for nephropathy and neuropathy, respectively (22).”
BackgroundSelf-citation(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
(1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80683-3 · Cited by 536
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.9.725 · Cited by 509
(1987) · Diabetes Care · doi:10.2337/diacare.10.1.1 · Cited by 479
Deckert, T., Poulsen, J. E., & Larsen, M. (1978) · Diabetologia · doi:10.1007/bf01228130 · Cited by 471
Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998) · JAMA · doi:10.1001/jama.280.2.140 · Cited by 469
Self-citationMonnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Self-citationFeldt-Rasmussen, B., Mathiesen, E., & Deckert, T. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91433-9 · Cited by 447
(1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30973-6 · Cited by 446
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Self-citationWood, J. R., Miller, K. M., Maahs, D. M., Beck, R. W., DiMeglio, L. A., Libman, I. M., Quinn, M., Tamborlane, W. V., Woerner, S. E., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1959 · Cited by 415
Albers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
Self-citationDecreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Little, R. R., Rohlfing, C. L., & Sacks, D. B. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148841 · Cited by 365
The DCCT Research Group (1986) · Diabetes · doi:10.2337/diab.35.5.530 · Cited by 331
Dahl-Jorgensen, K., Brinchmann-Hansen, O., Hanssen, K. F., Ganes, T., Kierulf, P., Smeland, E., Sandvik, L., & Aagenaes, O. (1986) · BMJ · doi:10.1136/bmj.293.6556.1195 · Cited by 329
Pop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Self-citationNot Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
(1995) · Diabetes Care · doi:10.2337/diacare.18.11.1415 · Cited by 305
Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 283
DCCT Research Group, B. N. (1995) · Annals of Neurology · doi:10.1002/ana.410380607 · Cited by 283
Cleary, P. A., Orchard, T. J., Genuth, S., Wong, N. D., Detrano, R., Backlund, J.-Y. C., Zinman, B., Jacobson, A., Sun, W., Lachin, J. M., et al. (2006) · Diabetes · doi:10.2337/db06-0653 · Cited by 264
Self-citationImproved Metabolic Control in Children and Adolescents With Type 1 Diabetes
Rosenbauer, J., Dost, A., Karges, B., Hungele, A., Stahl, A., Bächle, C., Gerstl, E. M., Kastendieck, C., Hofer, S. E., Holl, R. W., et al. (2012) · Diabetes Care · doi:10.2337/dc11-0993 · Cited by 263
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.11.1829 · Cited by 249
The Diabetes Control and Complications Trial Research Group (1996) · Diabetes Care · doi:10.2337/diacare.19.3.195 · Cited by 245
(1991) · PubMed · Cited by 245
White, N. H., Sun, W., Cleary, P. A., Tamborlane, W. V., Danis, R. P., Hainsworth, D. P., Davis, M. D., & for the DCCT-EDIC Research Group (2010) · Diabetes · doi:10.2337/db09-1216 · Cited by 235
Self-citationSexual Dysfunction in Women With Type 1 Diabetes
Enzlin, P., Rosen, R., Wiegel, M., Brown, J., Wessells, H., Gatcomb, P., Rutledge, B., Chan, K.-L., Cleary, P. A., & the DCCT/EDIC Research Group (2009) · Diabetes Care · doi:10.2337/dc08-1164 · Cited by 220
Self-citationTherapy for Diabetes Mellitus and Related Disorders
(2014) · American Diabetes Association eBooks · doi:10.2337/9781580405096 · Cited by 206
Gerstl, E.-M., Rabl, W., Rosenbauer, J., Gröbe, H., Hofer, S. E., Krause, U., & Holl, R. W. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-007-0586-9 · Cited by 201
Implications of the Diabetes Control and Complications Trial
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s25 · Cited by 182
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
Harjutsalo, V., Forsblom, C., & Groop, P.-H. (2011) · BMJ · doi:10.1136/bmj.d5364 · Cited by 173
Tamborlane, W. V., Bode, B. W., Buckingham, B. A., Chase, H. P., Clemons, R. D., Fox, L. A., Gilliam, L. K., Hirsch, I. B., Huang, E. S., Kollman, C., et al. (2008) · Cited by 167
The Diabetes Control and Complications Trial Research Group* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-4-199602150-00001 · Cited by 160
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 158
Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes
Downie, E., Craig, M. E., Hing, S. J., Cusumano, J. M., Chan, A. K. F., & Donaghue, K. C. (2011) · Diabetes Care · doi:10.2337/dc11-0102 · Cited by 155
Bulsara, M. K., Holman, C. D. J., Davis, E. A., & Jones, T. W. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2293 · Cited by 154
Control of Blood Glucose and Diabetic Vascular Disease
Siperstein, M. D., Foster, D. W., Knowles, H. C., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197705052961812 · Cited by 153
Control of blood glucose and diabetic vascular disease.
Fagerberg, S. E. (1980) · PubMed · Cited by 135
Pop‐Busui, R., Herman, W. H., Feldman, E. L., Low, P. A., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & Albers, J. W. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0120-8 · Cited by 129
Self-citationMusen, G., Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., Dahms, W. T., Bayless, M., Silvers, N., Harth, J., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0607 · Cited by 129
Self-citationCLINICAL EVALUATION OF VASCULAR DAMAGE IN DIABETES MELLITUS
Dolger, H. (1947) · JAMA · doi:10.1001/jama.1947.02880330011004 · Cited by 127
Steffes, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042143 · Cited by 125 · cited 1×
“ensure consistency of these methods over time (2,31).”
MethodPolak, J. F., Backlund, J. C., Cleary, P. A., Harrington, A. P., O’Leary, D. H., Lachin, J. M., & Nathan, D. M. (2011) · Diabetes · doi:10.2337/db10-0296 · Cited by 125
Self-citationDiabetes Control and Complications Trial (DCCT)
(NDIC), N. D. I. C. (2020) · Definitions · doi:10.32388/amqjns · Cited by 112
Nordwall, M., Arnqvist, H. J., Bojestig, M., & Ludvigsson, J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00472.x · Cited by 110
Delahanty, L. M., Simkins, S., & Camelon, K. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91748-f · Cited by 105
Boright, A. P., Paterson, A. D., Mirea, L., Bull, S. B., Mowjoodi, A., Scherer, S. W., & Zinman, B. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1238 · Cited by 102
Self-citationMedical Care for Patients with Diabetes: Epidemiologic Aspects
Harris, M. I. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00007 · Cited by 101
Al‐Kateb, H., Mirea, L., Xie, X., Sun, L., Liu, X., Chen, H., Bull, S. B., Boright, A. P., & Paterson, A. D. (2007) · Diabetes · doi:10.2337/db07-0376 · Cited by 99
Al‐Kateb, H., Boright, A. P., Mirea, L., Xie, X., Sutradhar, R., Mowjoodi, A., Bharaj, B., Liu, X., Bucksa, J. M., Arends, V. L., et al. (2007) · Diabetes · doi:10.2337/db07-1059 · Cited by 98
Self-citationEffect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes
Wessells, H., Penson, D. F., Cleary, P. A., Rutledge, B. N., Lachin, J. M., McVary, K. T., Schade, D. S., & Sarma, A. V. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.12.098 · Cited by 92
Self-citationSvensson, J., Johannesen, J., Mortensen, H. B., Nordly, S. B., & on behalf of The Danish Childhood Diabetes Registry (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00460.x · Cited by 76
Community Diabetes Care: A 10-year Perspective
Hiss, R. G., Anderson, R. M., Hess, G. E., Stepien, C. J., & Davis, W. K. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1124 · Cited by 74
Sarma, A. V., Kanaya, A. M., Nyberg, L. M., Kusek, J. W., Vittinghoff, E., Rutledge, B. N., Cleary, P. A., Gatcomb, P., & Brown, J. S. (2009) · Urology · doi:10.1016/j.urology.2008.11.009 · Cited by 52
Self-citationImplications of the Diabetes Control and Complications Trial
American Diabetes Association (1993) · Diabetes Care · doi:10.2337/diacare.16.11.1517 · Cited by 47
AVOIDANCE OF DEGENERATIVE LESIONS IN DIABETES MELLITUS
Boyd, J. D. (1942) · JAMA · doi:10.1001/jama.1942.02830090012003 · Cited by 31
Hotaling, J. M., Waggott, D. M., Goldberg, J. H., Jarvik, G. P., Paterson, A. D., Cleary, P. A., Lachin, J. M., Sarma, A. V., & Wessells, H. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.001 · Cited by 19
Self-citationAiello, L., Sun, W., Cleary, P. A., et al. (2013) · Investigative Ophthalmology & Visual Science · Cited by 2
Self-citation
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
Diabetic Retinopathy Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.025 · Cited by 717
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Self-citationDiabetes: Advances in Diagnosis and Treatment
Nathan, D. M. (2015) · JAMA · doi:10.1001/jama.2015.9536 · Cited by 384
Self-citation
Metadata
- Authors
- Nathan, D. M., Bayless, M., Cleary, P., Genuth, S., Gubitosi-Klug, R., Lachin, J. M., Lorenzi, G., Zinman, B., & for the DCCT/EDIC Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-11-16
- Volume
- 62
- Issue
- 12
- Pages
- 3976-3986
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2153558667
- Cited by
- 272
- References
- 91
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.